A Prospective, Randomized, Double blind, Placebo controlled clinical trial to evaluate efficacy and safety of MUKUL PURE in treating Acne

VIdya Herbs0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Both Male / Female of age between 18-50 yrs
•Facial acne, with:
•1.Inflammatory facial lesions (papules/pustules/nodules/cysts)
•2.Non inflammatory facial lesions if open (blackhead) and if closed (whitehead) comedones
•3.Mild to moderate acne with nodular abcesses, extensive lesions
•Willing to give written informed consent along with audio, video recording

•Patient not willing to comply with the study procedure
•Females who are pregnant or breast-feeding
•Skin diseases other than acne vulgaris
•Use of other topical or systemic treatments for acne
•Other significant medical conditions or clinically significant abnormal laboratory test results
•History of alcoholism or substance abuse and any other liver abnormalities
•Conditions in the opinion of the investigator make the patient unsuitable to participate in the study.
•History of Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids
•Patients under medication with contraceptive pills, Diltiazem, Anticoagulant and Propranolol.
•History of hypothyroidism or hyperthyroidism
•History of HIV
•Participation in another trial within 3 months prior to informed consent
•Certain medications that may interfere with the study medication (these will be identified by the study doctor).

发起方